Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Nature Reviews. Neuroscience|October 19, 2023
Neuron-oligodendroglial interactions in health and malignant diseaseKathryn R Taylor, Michelle MonjeCell|August 5, 2022
Invasive glioma cells: The malignant pioneers that follow the currentKathryn R Taylor, Michelle MonjeCancer Research|August 20, 2014
ACVR1 mutations in DIPG: lessons learned from FOPKathryn R Taylor, Maria Vinci, Alex N Bullock, et al.The Journal of Pathology|November 22, 2017
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistanceJoanna Selfe, Neil C Goddard, Alan McIntyre, et al.Nature|June 5, 2024
Myelin plasticity in the ventral tegmental area is required for opioid rewardBelgin Yalçın, Matthew B Pomrenze, Karen Malacon, et al.Menopause (New York, N.Y.)|October 1, 2024
Addressing menopause symptoms in the primary care setting: opportunity to bridge care delivery gapsMackenzie L Bevry, Emily R Stogdill, Catherine M Lea, et al.Cancer Cell|April 25, 2017
Transcriptional Dependencies in Diffuse Intrinsic Pontine GliomaSurya Nagaraja, Nicholas A Vitanza, Pamelyn J Woo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivoJane Renshaw, Kathryn R Taylor, Ryan Bishop, et al.Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.Acta Neuropathologica|September 25, 2015
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesDavid Castel, Cathy Philippe, Raphaël Calmon, et al.Pageof 3